| Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer P Jabbarzadeh Kaboli, A Rahmat, P Ismail, KH Ling European Journal of Pharmacology 740, 584-595, 2014 | 157 | 2014 |
| MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment PJ Kaboli, A Rahmat, P Ismail, KH Ling Pharmacological research 97, 104-121, 2015 | 150 | 2015 |
| Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer–A comprehensive review from chemotherapy to immunotherapy PJ Kaboli, F Salimian, S Aghapour, S Xiang, Q Zhao, M Li, X Wu, F Du, ... Pharmacological research 156, 104806, 2020 | 119 | 2020 |
| m1A regulated genes modulate PI3K/AKT/mTOR and ErbB pathways in gastrointestinal cancer Y Zhao, Q Zhao, PJ Kaboli, J Shen, M Li, X Wu, J Yin, H Zhang, Y Wu, ... Translational oncology 12 (10), 1323-1333, 2019 | 114 | 2019 |
| Engineered TCR-T cell immunotherapy in anticancer precision medicine: pros and cons Q Zhao, Y Jiang, S Xiang, PJ Kaboli, J Shen, Y Zhao, X Wu, F Du, M Li, ... Frontiers in immunology 12, 658753, 2021 | 92 | 2021 |
| An ethnobotanical survey of medicinal plants used by indigenous people in Zangelanlo district, Northeast Iran MS Amiri, P Jabbarzadeh, M Akhondi J Med Plants Res 6 (5), 749-753, 2012 | 72 | 2012 |
| Identification of prognostic genes in the tumor microenvironment of hepatocellular carcinoma S Xiang, J Li, J Shen, Y Zhao, X Wu, M Li, X Yang, PJ Kaboli, F Du, ... Frontiers in immunology 12, 653836, 2021 | 58 | 2021 |
| Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study P Jabbarzadeh Kaboli, MPY Leong, P Ismail, KH Ling Pharmacological Reports 71, 13-23, 2019 | 53 | 2019 |
| Conditional reprogramming: next generation cell culture X Wu, S Wang, M Li, J Li, J Shen, Y Zhao, J Pang, Q Wen, M Chen, B Wei, ... Acta Pharmaceutica Sinica B 10 (8), 1360-1381, 2020 | 52 | 2020 |
| A review of Penthorum chinense Pursh for hepatoprotection: traditional use, phytochemistry, pharmacology, toxicology and clinical trials A Wang, M Li, H Huang, Z Xiao, J Shen, Y Zhao, J Yin, PJ Kaboli, J Cao, ... Journal of ethnopharmacology 251, 112569, 2020 | 46 | 2020 |
| Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancer–contradictory effects and future perspectives PJ Kaboli, MA Khoshkbejari, M Mohammadi, A Abiri, R Mokhtarian, ... Biomedicine & Pharmacotherapy 121, 109635, 2020 | 46 | 2020 |
| Metagenome analysis of intestinal bacteria in healthy people, patients with inflammatory bowel disease and colorectal cancer Y Ma, Y Zhang, H Jiang, S Xiang, Y Zhao, M Xiao, F Du, H Ji, PJ Kaboli, ... Frontiers in cellular and infection microbiology 11, 599734, 2021 | 45 | 2021 |
| Characterization of chemical composition and prebiotic effect of a dietary medicinal plant Penthorum chinense Pursh J Yin, W Ren, B Wei, H Huang, M Li, X Wu, A Wang, Z Xiao, J Shen, ... Food chemistry 319, 126568, 2020 | 44 | 2020 |
| CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells J Yin, H Zhang, X Wu, Y Zhang, J Li, J Shen, Y Zhao, Z Xiao, L Lu, ... International journal of molecular medicine 45 (6), 1783-1792, 2020 | 38 | 2020 |
| Long non-coding RNAs: potential biomarkers and targets for hepatocellular carcinoma therapy and diagnosis D Yuan, Y Chen, X Li, J Li, Y Zhao, J Shen, F Du, PJ Kaboli, M Li, X Wu, ... International Journal of Biological Sciences 17 (1), 220, 2021 | 32 | 2021 |
| Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy PJ Kaboli, S Imani, M Jomhori, KH Ling American Journal of Cancer Research 11 (10), 5155, 2021 | 31 | 2021 |
| Molecular modeling, dynamics simulations, and binding efficiency of berberine derivatives: A new group of RAF inhibitors for cancer treatment P Jabbarzadeh Kaboli, P Ismail, KH Ling PLoS One 13 (3), e0193941, 2018 | 31 | 2018 |
| Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy Y Wu, J Li, PJ Kaboli, J Shen, X Wu, Y Zhao, H Ji, F Du, Y Zhou, Y Wang, ... Pharmacological research 155, 104691, 2020 | 30 | 2020 |
| Comprehensive understanding of B7 family in gastric cancer: expression profile, association with clinicopathological parameters and downstream targets D Li, S Xiang, J Shen, M Xiao, Y Zhao, X Wu, F Du, H Ji, M Li, Q Zhao, ... International journal of biological sciences 16 (4), 568, 2020 | 30 | 2020 |
| Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates PJ Kaboli, S Shabani, S Sharma, MP Nasr, H Yamaguchi, MC Hung American journal of cancer research 12 (4), 1671, 2022 | 28 | 2022 |
YUESHUI ZHAOUT Health Science Center at Houston-IMMVerified email at uth.tmc.edu
